Fluorine in PDB 8un3: Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Enzymatic activity of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
All present enzymatic activity of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One):
3.6.5.2;
Protein crystallography data
The structure of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One), PDB code: 8un3
was solved by
M.H.Ultsch,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.69 /
2.07
|
Space group
|
P 32
|
Cell size a, b, c (Å), α, β, γ (°)
|
69.217,
69.217,
166.92,
90,
90,
120
|
R / Rfree (%)
|
16.2 /
19.1
|
Other elements in 8un3:
The structure of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) also contains other interesting chemical elements:
Fluorine Binding Sites:
Pages:
>>> Page 1 <<<
Page 2, Binding sites: 11 -
16;
Binding sites:
The binding sites of Fluorine atom in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
(pdb code 8un3). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 16 binding sites of Fluorine where determined in the
Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One), PDB code: 8un3:
Jump to Fluorine binding site number:
1;
2;
3;
4;
5;
6;
7;
8;
9;
10;
Fluorine binding site 1 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 1 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:30.1
occ:1.00
|
F
|
A:XOI201
|
0.0
|
30.1
|
1.0
|
C6
|
A:XOI201
|
1.3
|
31.9
|
1.0
|
F2
|
A:XOI201
|
2.1
|
29.4
|
1.0
|
F1
|
A:XOI201
|
2.1
|
26.6
|
1.0
|
C5
|
A:XOI201
|
2.4
|
27.7
|
1.0
|
C7
|
A:XOI201
|
2.7
|
27.5
|
1.0
|
C4
|
A:XOI201
|
2.9
|
29.2
|
1.0
|
C12
|
A:XOI201
|
3.0
|
27.7
|
1.0
|
C8
|
A:XOI201
|
3.3
|
24.8
|
1.0
|
CD1
|
A:TYR96
|
3.5
|
26.1
|
1.0
|
CL
|
A:XOI201
|
3.5
|
35.3
|
1.0
|
CG1
|
A:VAL9
|
3.6
|
29.6
|
1.0
|
C1
|
A:XOI201
|
3.7
|
24.9
|
1.0
|
H7
|
A:XOI201
|
3.7
|
29.4
|
1.0
|
C11
|
A:XOI201
|
3.8
|
30.3
|
1.0
|
CB
|
A:VAL9
|
3.9
|
27.4
|
1.0
|
CE1
|
A:TYR96
|
4.0
|
28.6
|
1.0
|
C9
|
A:XOI201
|
4.0
|
23.3
|
1.0
|
H5
|
A:XOI201
|
4.2
|
41.2
|
1.0
|
N
|
A:XOI201
|
4.2
|
31.3
|
1.0
|
C
|
A:XOI201
|
4.3
|
34.6
|
1.0
|
C10
|
A:XOI201
|
4.3
|
29.1
|
1.0
|
H3
|
A:XOI201
|
4.3
|
41.2
|
1.0
|
O
|
A:XOI201
|
4.6
|
29.1
|
1.0
|
CG
|
A:TYR96
|
4.6
|
26.0
|
1.0
|
H9
|
A:XOI201
|
4.6
|
31.2
|
1.0
|
C2
|
A:XOI201
|
4.8
|
28.3
|
1.0
|
CG2
|
A:VAL9
|
4.8
|
31.0
|
1.0
|
CB
|
A:TYR96
|
4.8
|
31.1
|
1.0
|
C3
|
A:XOI201
|
5.0
|
30.0
|
1.0
|
|
Fluorine binding site 2 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 2 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:26.6
occ:1.00
|
F1
|
A:XOI201
|
0.0
|
26.6
|
1.0
|
C6
|
A:XOI201
|
1.3
|
31.9
|
1.0
|
F
|
A:XOI201
|
2.1
|
30.1
|
1.0
|
F2
|
A:XOI201
|
2.1
|
29.4
|
1.0
|
C5
|
A:XOI201
|
2.4
|
27.7
|
1.0
|
H5
|
A:XOI201
|
2.7
|
41.2
|
1.0
|
C1
|
A:XOI201
|
3.1
|
24.9
|
1.0
|
C
|
A:XOI201
|
3.3
|
34.6
|
1.0
|
CB
|
A:GLN99
|
3.4
|
25.2
|
1.0
|
C4
|
A:XOI201
|
3.4
|
29.2
|
1.0
|
O
|
A:TYR96
|
3.5
|
30.8
|
1.0
|
H7
|
A:XOI201
|
3.6
|
29.4
|
1.0
|
H3
|
A:XOI201
|
3.6
|
41.2
|
1.0
|
C7
|
A:XOI201
|
3.8
|
27.5
|
1.0
|
CD1
|
A:TYR96
|
3.8
|
26.1
|
1.0
|
C8
|
A:XOI201
|
3.9
|
24.8
|
1.0
|
CA
|
A:TYR96
|
3.9
|
28.3
|
1.0
|
CG1
|
A:ILE100
|
3.9
|
24.9
|
1.0
|
N
|
A:ILE100
|
4.1
|
27.6
|
1.0
|
C
|
A:TYR96
|
4.2
|
28.8
|
1.0
|
H4
|
A:XOI201
|
4.2
|
41.2
|
1.0
|
CB
|
A:TYR96
|
4.2
|
31.1
|
1.0
|
C
|
A:GLN99
|
4.3
|
27.3
|
1.0
|
CG
|
A:GLN99
|
4.3
|
23.2
|
1.0
|
C2
|
A:XOI201
|
4.4
|
28.3
|
1.0
|
CA
|
A:GLN99
|
4.4
|
28.0
|
1.0
|
CG
|
A:TYR96
|
4.5
|
26.0
|
1.0
|
CD1
|
A:ILE100
|
4.6
|
21.1
|
1.0
|
N
|
A:XOI201
|
4.6
|
31.3
|
1.0
|
C12
|
A:XOI201
|
4.7
|
27.7
|
1.0
|
CE1
|
A:TYR96
|
4.8
|
28.6
|
1.0
|
CG1
|
A:VAL9
|
4.8
|
29.6
|
1.0
|
CA
|
A:ILE100
|
4.8
|
30.9
|
1.0
|
C9
|
A:XOI201
|
4.9
|
23.3
|
1.0
|
O
|
A:GLN99
|
4.9
|
30.7
|
1.0
|
CB
|
A:ILE100
|
5.0
|
25.5
|
1.0
|
N
|
A:GLN99
|
5.0
|
27.4
|
1.0
|
C3
|
A:XOI201
|
5.0
|
30.0
|
1.0
|
O
|
A:HIS95
|
5.0
|
24.6
|
1.0
|
|
Fluorine binding site 3 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 3 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:29.4
occ:1.00
|
F2
|
A:XOI201
|
0.0
|
29.4
|
1.0
|
C6
|
A:XOI201
|
1.3
|
31.9
|
1.0
|
F
|
A:XOI201
|
2.1
|
30.1
|
1.0
|
F1
|
A:XOI201
|
2.1
|
26.6
|
1.0
|
C5
|
A:XOI201
|
2.4
|
27.7
|
1.0
|
H3
|
A:XOI201
|
2.5
|
41.2
|
1.0
|
H5
|
A:XOI201
|
2.7
|
41.2
|
1.0
|
C
|
A:XOI201
|
2.7
|
34.6
|
1.0
|
C1
|
A:XOI201
|
2.8
|
24.9
|
1.0
|
CG1
|
A:VAL9
|
3.6
|
29.6
|
1.0
|
C4
|
A:XOI201
|
3.6
|
29.2
|
1.0
|
CG1
|
A:ILE100
|
3.6
|
24.9
|
1.0
|
H4
|
A:XOI201
|
3.8
|
41.2
|
1.0
|
C2
|
A:XOI201
|
4.2
|
28.3
|
1.0
|
C7
|
A:XOI201
|
4.2
|
27.5
|
1.0
|
CD1
|
A:ILE100
|
4.2
|
21.1
|
1.0
|
CE2
|
A:PHE78
|
4.4
|
26.0
|
1.0
|
CB
|
A:VAL9
|
4.4
|
27.4
|
1.0
|
CD2
|
A:PHE78
|
4.5
|
24.7
|
1.0
|
CL
|
A:XOI201
|
4.6
|
35.3
|
1.0
|
C12
|
A:XOI201
|
4.7
|
27.7
|
1.0
|
SD
|
A:MET72
|
4.7
|
33.8
|
1.0
|
N
|
A:XOI201
|
4.7
|
31.3
|
1.0
|
CG
|
A:MET72
|
4.8
|
30.4
|
1.0
|
O
|
A:TYR96
|
4.8
|
30.8
|
1.0
|
H6
|
A:XOI201
|
4.8
|
33.6
|
1.0
|
CB
|
A:ILE100
|
4.9
|
25.5
|
1.0
|
N
|
A:ILE100
|
4.9
|
27.6
|
1.0
|
CG2
|
A:VAL9
|
4.9
|
31.0
|
1.0
|
C3
|
A:XOI201
|
4.9
|
30.0
|
1.0
|
C8
|
A:XOI201
|
4.9
|
24.8
|
1.0
|
CA
|
A:ILE100
|
4.9
|
30.9
|
1.0
|
|
Fluorine binding site 4 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 4 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:31.1
occ:1.00
|
F3
|
A:XOI201
|
0.0
|
31.1
|
1.0
|
C23
|
A:XOI201
|
1.4
|
29.6
|
1.0
|
H2
|
A:XOI201
|
2.0
|
35.1
|
1.0
|
C24
|
A:XOI201
|
2.3
|
31.4
|
1.0
|
C22
|
A:XOI201
|
2.4
|
32.1
|
1.0
|
H20
|
A:XOI201
|
2.4
|
37.3
|
1.0
|
H19
|
A:XOI201
|
2.4
|
38.2
|
1.0
|
H24
|
A:XOI201
|
2.4
|
36.9
|
1.0
|
O
|
B:HOH359
|
2.5
|
31.3
|
1.0
|
O
|
A:HOH387
|
2.8
|
36.5
|
1.0
|
N5
|
A:XOI201
|
3.0
|
29.7
|
1.0
|
C25
|
A:XOI201
|
3.1
|
31.1
|
1.0
|
H18
|
A:XOI201
|
3.2
|
38.2
|
1.0
|
C21
|
A:XOI201
|
3.2
|
31.5
|
1.0
|
H21
|
A:XOI201
|
3.2
|
37.3
|
1.0
|
H1
|
A:XOI201
|
3.6
|
37.5
|
1.0
|
H22
|
A:XOI201
|
3.6
|
36.9
|
1.0
|
OD1
|
A:ASP92
|
3.7
|
31.4
|
1.0
|
O
|
C:HOH383
|
3.8
|
35.8
|
1.0
|
H23
|
A:XOI201
|
4.0
|
36.9
|
1.0
|
O
|
C:HOH302
|
4.3
|
30.0
|
1.0
|
CG
|
A:ASP92
|
4.5
|
30.7
|
1.0
|
C20
|
A:XOI201
|
4.6
|
30.2
|
1.0
|
CG
|
A:HIS95
|
4.8
|
26.2
|
1.0
|
H16
|
A:XOI201
|
4.9
|
35.8
|
1.0
|
O1
|
A:XOI201
|
4.9
|
27.8
|
1.0
|
CB
|
A:HIS95
|
4.9
|
27.1
|
1.0
|
|
Fluorine binding site 5 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 5 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 5 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:27.9
occ:1.00
|
F
|
B:XOI201
|
0.0
|
27.9
|
1.0
|
C6
|
B:XOI201
|
1.3
|
31.5
|
1.0
|
F1
|
B:XOI201
|
2.1
|
30.3
|
1.0
|
F2
|
B:XOI201
|
2.1
|
33.6
|
1.0
|
C5
|
B:XOI201
|
2.4
|
26.0
|
1.0
|
C7
|
B:XOI201
|
2.7
|
27.4
|
1.0
|
C4
|
B:XOI201
|
2.9
|
29.1
|
1.0
|
C12
|
B:XOI201
|
3.0
|
29.7
|
1.0
|
C8
|
B:XOI201
|
3.1
|
30.5
|
1.0
|
CD1
|
B:TYR96
|
3.4
|
27.8
|
1.0
|
H7
|
B:XOI201
|
3.5
|
36.2
|
1.0
|
CG1
|
B:VAL9
|
3.7
|
28.1
|
1.0
|
CL
|
B:XOI201
|
3.7
|
38.4
|
1.0
|
C1
|
B:XOI201
|
3.7
|
26.6
|
1.0
|
C11
|
B:XOI201
|
3.7
|
33.2
|
1.0
|
C9
|
B:XOI201
|
3.8
|
27.2
|
1.0
|
CE1
|
B:TYR96
|
3.9
|
26.4
|
1.0
|
H5
|
B:XOI201
|
3.9
|
41.0
|
1.0
|
CB
|
B:VAL9
|
4.0
|
30.1
|
1.0
|
C10
|
B:XOI201
|
4.1
|
30.1
|
1.0
|
N
|
B:XOI201
|
4.2
|
28.1
|
1.0
|
C
|
B:XOI201
|
4.3
|
34.5
|
1.0
|
O
|
B:XOI201
|
4.5
|
36.3
|
1.0
|
H9
|
B:XOI201
|
4.5
|
43.9
|
1.0
|
CG
|
B:TYR96
|
4.5
|
29.3
|
1.0
|
CG2
|
B:VAL9
|
4.8
|
28.0
|
1.0
|
CB
|
B:TYR96
|
4.8
|
26.8
|
1.0
|
C2
|
B:XOI201
|
4.8
|
32.6
|
1.0
|
N4
|
B:XOI201
|
4.8
|
28.9
|
1.0
|
H3
|
B:XOI201
|
4.8
|
41.0
|
1.0
|
CA
|
B:TYR96
|
5.0
|
30.0
|
1.0
|
|
Fluorine binding site 6 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 6 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 6 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:30.3
occ:1.00
|
F1
|
B:XOI201
|
0.0
|
30.3
|
1.0
|
C6
|
B:XOI201
|
1.3
|
31.5
|
1.0
|
F
|
B:XOI201
|
2.1
|
27.9
|
1.0
|
F2
|
B:XOI201
|
2.1
|
33.6
|
1.0
|
C5
|
B:XOI201
|
2.4
|
26.0
|
1.0
|
H5
|
B:XOI201
|
2.6
|
41.0
|
1.0
|
C1
|
B:XOI201
|
3.1
|
26.6
|
1.0
|
C
|
B:XOI201
|
3.3
|
34.5
|
1.0
|
CB
|
B:GLN99
|
3.3
|
26.9
|
1.0
|
C4
|
B:XOI201
|
3.4
|
29.1
|
1.0
|
O
|
B:TYR96
|
3.5
|
27.6
|
1.0
|
H7
|
B:XOI201
|
3.6
|
36.2
|
1.0
|
C7
|
B:XOI201
|
3.8
|
27.4
|
1.0
|
CG1
|
B:ILE100
|
3.8
|
28.1
|
1.0
|
C8
|
B:XOI201
|
3.9
|
30.5
|
1.0
|
H4
|
B:XOI201
|
3.9
|
41.0
|
1.0
|
CA
|
B:TYR96
|
4.0
|
30.0
|
1.0
|
CD1
|
B:TYR96
|
4.0
|
27.8
|
1.0
|
H3
|
B:XOI201
|
4.1
|
41.0
|
1.0
|
N
|
B:ILE100
|
4.1
|
29.3
|
1.0
|
C
|
B:TYR96
|
4.2
|
25.4
|
1.0
|
C
|
B:GLN99
|
4.2
|
29.7
|
1.0
|
CG
|
B:GLN99
|
4.2
|
27.6
|
1.0
|
CA
|
B:GLN99
|
4.3
|
29.7
|
1.0
|
CB
|
B:TYR96
|
4.4
|
26.8
|
1.0
|
C2
|
B:XOI201
|
4.4
|
32.6
|
1.0
|
CD1
|
B:ILE100
|
4.5
|
25.7
|
1.0
|
N
|
B:XOI201
|
4.6
|
28.1
|
1.0
|
CG
|
B:TYR96
|
4.7
|
29.3
|
1.0
|
C12
|
B:XOI201
|
4.7
|
29.7
|
1.0
|
CA
|
B:ILE100
|
4.7
|
28.8
|
1.0
|
O
|
B:GLN99
|
4.8
|
30.2
|
1.0
|
N
|
B:GLN99
|
4.8
|
32.8
|
1.0
|
C9
|
B:XOI201
|
4.9
|
27.2
|
1.0
|
CB
|
B:ILE100
|
4.9
|
32.5
|
1.0
|
CG1
|
B:VAL9
|
5.0
|
28.1
|
1.0
|
CE1
|
B:TYR96
|
5.0
|
26.4
|
1.0
|
C3
|
B:XOI201
|
5.0
|
26.0
|
1.0
|
|
Fluorine binding site 7 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 7 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 7 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:33.6
occ:1.00
|
F2
|
B:XOI201
|
0.0
|
33.6
|
1.0
|
C6
|
B:XOI201
|
1.3
|
31.5
|
1.0
|
F
|
B:XOI201
|
2.1
|
27.9
|
1.0
|
F1
|
B:XOI201
|
2.1
|
30.3
|
1.0
|
H5
|
B:XOI201
|
2.3
|
41.0
|
1.0
|
C5
|
B:XOI201
|
2.4
|
26.0
|
1.0
|
C
|
B:XOI201
|
2.9
|
34.5
|
1.0
|
C1
|
B:XOI201
|
2.9
|
26.6
|
1.0
|
H3
|
B:XOI201
|
3.1
|
41.0
|
1.0
|
CG1
|
B:VAL9
|
3.6
|
28.1
|
1.0
|
C4
|
B:XOI201
|
3.6
|
29.1
|
1.0
|
CG1
|
B:ILE100
|
3.7
|
28.1
|
1.0
|
H4
|
B:XOI201
|
3.9
|
41.0
|
1.0
|
C7
|
B:XOI201
|
4.2
|
27.4
|
1.0
|
C2
|
B:XOI201
|
4.2
|
32.6
|
1.0
|
CD1
|
B:ILE100
|
4.3
|
25.7
|
1.0
|
CE2
|
B:PHE78
|
4.3
|
30.1
|
1.0
|
CB
|
B:VAL9
|
4.4
|
30.1
|
1.0
|
CD2
|
B:PHE78
|
4.5
|
26.1
|
1.0
|
SD
|
B:MET72
|
4.5
|
42.1
|
1.0
|
CL
|
B:XOI201
|
4.6
|
38.4
|
1.0
|
C12
|
B:XOI201
|
4.6
|
29.7
|
1.0
|
N
|
B:XOI201
|
4.7
|
28.1
|
1.0
|
CG
|
B:MET72
|
4.7
|
30.4
|
1.0
|
CG2
|
B:VAL9
|
4.8
|
28.0
|
1.0
|
O
|
B:TYR96
|
4.8
|
27.6
|
1.0
|
C8
|
B:XOI201
|
4.9
|
30.5
|
1.0
|
CB
|
B:MET72
|
4.9
|
38.6
|
1.0
|
H6
|
B:XOI201
|
4.9
|
38.7
|
1.0
|
C3
|
B:XOI201
|
5.0
|
26.0
|
1.0
|
CD1
|
B:TYR96
|
5.0
|
27.8
|
1.0
|
CB
|
B:ILE100
|
5.0
|
32.5
|
1.0
|
H7
|
B:XOI201
|
5.0
|
36.2
|
1.0
|
|
Fluorine binding site 8 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 8 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 8 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F201
b:36.0
occ:1.00
|
F3
|
B:XOI201
|
0.0
|
36.0
|
1.0
|
C23
|
B:XOI201
|
1.4
|
30.9
|
1.0
|
H2
|
B:XOI201
|
2.0
|
36.7
|
1.0
|
C24
|
B:XOI201
|
2.3
|
33.4
|
1.0
|
C22
|
B:XOI201
|
2.3
|
32.6
|
1.0
|
H19
|
B:XOI201
|
2.4
|
38.8
|
1.0
|
H20
|
B:XOI201
|
2.4
|
39.7
|
1.0
|
H24
|
B:XOI201
|
2.6
|
41.0
|
1.0
|
O
|
B:HOH369
|
2.7
|
40.5
|
1.0
|
N5
|
B:XOI201
|
3.0
|
29.0
|
1.0
|
H18
|
B:XOI201
|
3.2
|
38.8
|
1.0
|
H21
|
B:XOI201
|
3.2
|
39.7
|
1.0
|
C25
|
B:XOI201
|
3.2
|
34.5
|
1.0
|
C21
|
B:XOI201
|
3.3
|
29.1
|
1.0
|
O
|
A:HOH343
|
3.4
|
39.5
|
1.0
|
O
|
A:HOH353
|
3.6
|
41.1
|
1.0
|
OD1
|
B:ASP92
|
3.7
|
38.0
|
1.0
|
NZ
|
B:LYS88
|
3.7
|
39.5
|
1.0
|
H22
|
B:XOI201
|
3.7
|
41.0
|
1.0
|
H1
|
B:XOI201
|
3.7
|
34.5
|
1.0
|
O
|
D:HOH387
|
4.1
|
35.3
|
1.0
|
H23
|
B:XOI201
|
4.2
|
41.0
|
1.0
|
CG
|
B:ASP92
|
4.2
|
33.2
|
1.0
|
O
|
D:HOH347
|
4.4
|
35.2
|
1.0
|
OD2
|
B:ASP92
|
4.6
|
38.1
|
1.0
|
C20
|
B:XOI201
|
4.6
|
34.1
|
1.0
|
CB
|
B:HIS95
|
4.8
|
29.3
|
1.0
|
H16
|
B:XOI201
|
4.8
|
40.5
|
1.0
|
CG
|
B:HIS95
|
4.9
|
31.1
|
1.0
|
O1
|
B:XOI201
|
4.9
|
31.6
|
1.0
|
CE
|
B:LYS88
|
4.9
|
42.0
|
1.0
|
O
|
B:HOH393
|
5.0
|
40.1
|
1.0
|
|
Fluorine binding site 9 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 9 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 9 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F201
b:30.5
occ:1.00
|
F
|
C:XOI201
|
0.0
|
30.5
|
1.0
|
C6
|
C:XOI201
|
1.3
|
30.1
|
1.0
|
F2
|
C:XOI201
|
2.1
|
28.6
|
1.0
|
F1
|
C:XOI201
|
2.1
|
29.4
|
1.0
|
C5
|
C:XOI201
|
2.4
|
25.4
|
1.0
|
C7
|
C:XOI201
|
2.7
|
28.8
|
1.0
|
C4
|
C:XOI201
|
2.9
|
28.1
|
1.0
|
C12
|
C:XOI201
|
3.0
|
29.8
|
1.0
|
C8
|
C:XOI201
|
3.3
|
24.5
|
1.0
|
CD1
|
C:TYR96
|
3.5
|
27.1
|
1.0
|
CL
|
C:XOI201
|
3.5
|
31.6
|
1.0
|
CG1
|
C:VAL9
|
3.6
|
27.2
|
1.0
|
H7
|
C:XOI201
|
3.6
|
29.0
|
1.0
|
C1
|
C:XOI201
|
3.7
|
21.6
|
1.0
|
CB
|
C:VAL9
|
3.8
|
22.2
|
1.0
|
C11
|
C:XOI201
|
3.8
|
32.0
|
1.0
|
CE1
|
C:TYR96
|
4.0
|
26.6
|
1.0
|
C9
|
C:XOI201
|
4.1
|
23.1
|
1.0
|
N
|
C:XOI201
|
4.2
|
31.2
|
1.0
|
H5
|
C:XOI201
|
4.2
|
30.4
|
1.0
|
C
|
C:XOI201
|
4.3
|
25.7
|
1.0
|
C10
|
C:XOI201
|
4.3
|
30.3
|
1.0
|
H3
|
C:XOI201
|
4.4
|
30.4
|
1.0
|
CG
|
C:TYR96
|
4.5
|
27.7
|
1.0
|
CG2
|
C:VAL9
|
4.6
|
28.6
|
1.0
|
O
|
C:XOI201
|
4.6
|
32.2
|
1.0
|
H9
|
C:XOI201
|
4.7
|
34.9
|
1.0
|
CB
|
C:TYR96
|
4.8
|
32.0
|
1.0
|
C2
|
C:XOI201
|
4.8
|
24.9
|
1.0
|
C3
|
C:XOI201
|
5.0
|
29.5
|
1.0
|
CA
|
C:TYR96
|
5.0
|
31.6
|
1.0
|
|
Fluorine binding site 10 out
of 16 in 8un3
Go back to
Fluorine Binding Sites List in 8un3
Fluorine binding site 10 out
of 16 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 10 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F201
b:29.4
occ:1.00
|
F1
|
C:XOI201
|
0.0
|
29.4
|
1.0
|
C6
|
C:XOI201
|
1.3
|
30.1
|
1.0
|
F
|
C:XOI201
|
2.1
|
30.5
|
1.0
|
F2
|
C:XOI201
|
2.1
|
28.6
|
1.0
|
C5
|
C:XOI201
|
2.4
|
25.4
|
1.0
|
H5
|
C:XOI201
|
2.8
|
30.4
|
1.0
|
C1
|
C:XOI201
|
3.2
|
21.6
|
1.0
|
CB
|
C:GLN99
|
3.3
|
26.3
|
1.0
|
C4
|
C:XOI201
|
3.3
|
28.1
|
1.0
|
O
|
C:TYR96
|
3.4
|
31.9
|
1.0
|
C
|
C:XOI201
|
3.4
|
25.7
|
1.0
|
H7
|
C:XOI201
|
3.5
|
29.0
|
1.0
|
C7
|
C:XOI201
|
3.7
|
28.8
|
1.0
|
C8
|
C:XOI201
|
3.8
|
24.5
|
1.0
|
CA
|
C:TYR96
|
3.8
|
31.6
|
1.0
|
H3
|
C:XOI201
|
3.8
|
30.4
|
1.0
|
CD1
|
C:TYR96
|
3.9
|
27.1
|
1.0
|
CG1
|
C:ILE100
|
3.9
|
24.6
|
1.0
|
C
|
C:TYR96
|
4.0
|
27.5
|
1.0
|
N
|
C:ILE100
|
4.1
|
31.4
|
1.0
|
CB
|
C:TYR96
|
4.2
|
32.0
|
1.0
|
CG
|
C:GLN99
|
4.3
|
23.5
|
1.0
|
C
|
C:GLN99
|
4.3
|
28.3
|
1.0
|
CA
|
C:GLN99
|
4.3
|
30.8
|
1.0
|
H4
|
C:XOI201
|
4.3
|
30.4
|
1.0
|
C2
|
C:XOI201
|
4.4
|
24.9
|
1.0
|
CG
|
C:TYR96
|
4.5
|
27.7
|
1.0
|
N
|
C:XOI201
|
4.5
|
31.2
|
1.0
|
C12
|
C:XOI201
|
4.6
|
29.8
|
1.0
|
CD1
|
C:ILE100
|
4.6
|
23.4
|
1.0
|
CA
|
C:ILE100
|
4.8
|
30.6
|
1.0
|
C9
|
C:XOI201
|
4.8
|
23.1
|
1.0
|
CE1
|
C:TYR96
|
4.8
|
26.6
|
1.0
|
O
|
C:HIS95
|
4.9
|
26.2
|
1.0
|
N
|
C:GLN99
|
4.9
|
30.1
|
1.0
|
O
|
C:GLN99
|
4.9
|
30.6
|
1.0
|
CG1
|
C:VAL9
|
4.9
|
27.2
|
1.0
|
CB
|
C:ILE100
|
4.9
|
28.5
|
1.0
|
N
|
C:TYR96
|
5.0
|
29.7
|
1.0
|
C3
|
C:XOI201
|
5.0
|
29.5
|
1.0
|
|
Reference:
C.Nilewski,
M.H.Ultsch.
N/A N/A.
Page generated: Sat Aug 3 01:08:37 2024
|